Published in Gut on November 26, 2010
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci (2012) 1.49
Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. Dig Dis Sci (2015) 1.43
Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol (2012) 1.24
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
How to interpret hydrogen breath tests. J Neurogastroenterol Motil (2011) 1.19
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci (2012) 1.15
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model. Dig Dis Sci (2014) 1.08
Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World J Gastroenterol (2014) 1.06
The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci (2013) 1.00
Microflora modulation of motility. J Neurogastroenterol Motil (2011) 0.91
New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) (2015) 0.91
Methods for the assessment of small-bowel and colonic transit. Semin Nucl Med (2012) 0.91
Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol (2013) 0.89
Advances in motility testing--current and novel approaches. Nat Rev Gastroenterol Hepatol (2013) 0.85
Breath tests and irritable bowel syndrome. World J Gastroenterol (2014) 0.84
Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study. Gut Pathog (2012) 0.84
Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome. Clin Exp Gastroenterol (2015) 0.83
Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil (2013) 0.83
Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol (2012) 0.82
Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol (2015) 0.81
Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients. World J Gastroenterol (2015) 0.81
Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clin Transl Gastroenterol (2016) 0.80
Overgrowth of the indigenous gut microbiome and irritable bowel syndrome. World J Gastroenterol (2014) 0.79
Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome. BMC Complement Altern Med (2013) 0.79
No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep (2015) 0.79
The Lactulose Breath Test in Irritable Bowel Syndrome: Is It All Hot Air? Dig Dis Sci (2016) 0.79
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver (2017) 0.79
Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Ann Clin Microbiol Antimicrob (2014) 0.78
Measurement of Gastrointestinal and Colonic Motor Functions in Humans and Animals. Cell Mol Gastroenterol Hepatol (2016) 0.78
Enhancing High Value Care in Gastroenterology Practice. Clin Gastroenterol Hepatol (2016) 0.77
Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders. United European Gastroenterol J (2016) 0.76
Lactulose hydrogen breath test and functional symptoms in pediatric patients. Dig Dis Sci (2012) 0.76
Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study. World J Gastroenterol (2012) 0.76
Measurement of oro-caecal transit time by magnetic resonance imaging. Eur Radiol (2015) 0.76
Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. BMC Gastroenterol (2016) 0.76
Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol (2017) 0.75
Combined orocecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects orocecal transit, not small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gastroenterology (2011) 0.75
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea. Gastroenterology (2016) 0.75
Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects. J Korean Med Sci (2015) 0.75
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol (2017) 0.75
Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract (2016) 0.75
Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr (2016) 0.75
Mechanism-Oriented Therapy of Irritable Bowel Syndrome. Adv Ther (2016) 0.75
SIBO in gastroparesis: sci-fi or science fact? Dig Dis Sci (2014) 0.75
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol (2006) 2.34
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J Physiol (2006) 2.07
A low-residue breakfast improves patient tolerance without impacting quality of low-volume colon cleansing prior to colonoscopy: a randomized trial. Am J Gastroenterol (2013) 2.06
The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc (2002) 2.02
Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol (2006) 1.49
Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol (2003) 1.28
Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol (2008) 1.25
A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Am J Gastroenterol (2013) 1.24
Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.16
Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study. Gastrointest Endosc (2013) 1.14
A review of current issues underlying colon cleansing before colonoscopy. Can J Gastroenterol (2007) 1.04
Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol (2010) 1.04
Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol (2007) 1.00
Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology (2011) 0.99
Recognizing the clinical contraindications to the use of oral sodium phosphate for colon cleansing: a case study. Can J Gastroenterol (2004) 0.91
LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.91
Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol (2007) 0.87
Investigating and treating fecal incontinence: when and how. Can J Gastroenterol (2009) 0.86
Munc18/SNARE proteins' regulation of exocytosis in guinea pig duodenal Brunner's gland acini. World J Gastroenterol (2008) 0.84
Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons. J Physiol (2009) 0.83
The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol (2008) 0.82
TNFalpha is a key mediator of the pronociceptive effects of mucosal supernatant from human ulcerative colitis on colonic DRG neurons. Gut (2010) 0.82
Alterations in capsaicin-evoked electrolyte transport during the evolution of guinea pig TNBS ileitis. Am J Physiol Gastrointest Liver Physiol (2002) 0.80
Mucosal stimulation activates secretomotor neurons via long myenteric pathways in guinea pig ileum. Am J Physiol Gastrointest Liver Physiol (2006) 0.80
Evaluation of funding gastroenterology research in Canada illustrates the beneficial role of partnerships. Can J Gastroenterol (2013) 0.80
Training general surgery residents on the gastroenterology service: a look at the successes and challenges. Can J Gastroenterol (2009) 0.79
Potassium currents regulating secretion from Brunner's glands in guinea pig duodenum. Am J Physiol Gastrointest Liver Physiol (2003) 0.77
The Canadian Digestive Health Foundation research program. Can J Gastroenterol (2002) 0.75
Research Topics in Gastrointestinal Disease: a report on the 10th meeting and an announcement of the 11th meeting. Can J Gastroenterol (2011) 0.75